---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-016390"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T01:00:58.987738+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics receives Nasdaq delisting notice for bid price and MVPHS noncompliance

## Summary
- Failed to regain compliance with minimum bid price ($1.00) by Feb 3, 2025 and MVPHS ($15M) by Feb 4, 2025.
- Nasdaq Staff notified company on Feb 5, 2025 that securities are subject to delisting unless hearing requested.
- Company plans to request hearing before Nasdaq Hearing Panel; will present plan to evidence compliance.
- Previously disclosed noncompliance with MVLS Rule; hearing request stays delisting action pending panel decision.
- No assurance that Panel will grant continued listing or that compliance can be achieved.

## SEC filing metadata
- accession: 0000950170-25-016390
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017025016390/0000950170-25-016390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025016390/hcwb-20250205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-016390
- JSON: https://secwatch.observer/filing/0000950170-25-016390.json
- Plain text: https://secwatch.observer/filing/0000950170-25-016390.txt

## Source-grounded claims
- claim_id: d5283b457b910b12189bd07d97d0f2e491bc453a
  claim: HCW Biologics Inc. received a nasdaq delisting notice notice regarding other (rules 5810(c)(3)(A), 5450(b)(2)).
  evidence_excerpt: February 5, 2025, the Staff notified the Company that its securities were subject to delisting from Nasdaq unless the Company timely requests a hearing before the Nasdaq Hearing Panel (the “Panel”). As previously disclos
  evidence_url: https://www.sec.gov/Archives/edgar/data/1828673/000095017025016390/0000950170-25-016390-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.